Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding.

Apata, Jummai; Lyons, Jennifer G; Bradley, Marie C; Ma, Yong; Kempner, Maria E; Kim, Ivone; Eworuke, Efe; Pennap, Dinci; Mosholder, Andrew.

Apata J; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Lyons JG; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Bradley MC; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Ma Y; Division of Biometrics, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Kempner ME; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Kim I; Division of Pharmacovigilance, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Eworuke E; Formerly at Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Pennap D; Formerly at Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Mosholder A; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.